Mega parks would give boost to drug manufacturing: Ahir

The government will provide a fresh focus on the bulk drug manufacturing, which is likely to get a boost with the development of mega parks, Union Minister of State for Chemicals and Fertilisers Hansraj Ahir said here today.
The pharma industry will give boost to GDP growth as it is currently exporting to over 200 countries, Ahir said, after inaugurating an industry exhibition promoted by the Pharmaceutical Exports Promotion Council here.
The thrust to bulk drug manufacturing was in line with NDA government's Make-in-India campaign, he said.
Talking to the reporters, Drug Controller General G N Singh said, "In the current year, our main focus is to get the recognition for the Indian Pharmacopoeia from other drug regulators. We are talking to all drug regulators and reassuring them that Pharmexcil would make its best efforts to ensure supply of best quality drugs at affordable prices."

Recognition of the Indian Pharmacopoeia will help significantly in manufacturing of quality drugs at affordable prices, Pharmexcil director general P V Appaji said.
"With increasing R&D spends, domestic pharmaceutical sector has become a cost-effective centre for world class research as also for contract R&D. Domestic companies in recent years have produced many cost-effective drugs that are affordable to the masses," Pharmexcil Chairman Ashutosh Gupta said.